Ibrutinib from Alfa Chemistry

Description

Ibrutinib is an orally administered anticancer drug for the treatment of mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL) and Waldenstrm's macroglobulinemia (WM ' also known as lymphoplasmacytic lymphoma).